Nuvectis Pharma GAAP EPS of $0.27
Source: SeekingAlpha
2025-05-06 11:18:48 ET
More on Nuvectis Pharma
- Nuvectis: Additional Data In Q2 Of 2025 Could Allow It To Stage A Comeback
- Nuvectis Pharma announces pricing of $13.5M public offering
- Seeking Alpha’s Quant Rating on Nuvectis Pharma
Read the full article on Seeking Alpha
For further details see:
Nuvectis Pharma GAAP EPS of $0.27
Nuvectis Pharma Inc.
NASDAQ: NVCT
NVCT Trading
-1.0% G/L:
$8.95 Last:
10,312 Volume:
$9.10 Open:
NVCT Latest News
February 11, 2026 07:30:00 am
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
NVCT Stock Data
$223,874,191
14,667,089
29.18%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Fort Lee
